EV repair cost concerns are a key barrier to UK adoption

GlobalData finds 36.9% of UK respondents are being deterred from switching to an EV by concerns over maintenance/repair costs.

FDA MACI Approval Tests Vericel’s Capacity Plans And Growth Story

Vericel received FDA approval for commercial manufacturing of MACI at its new Burlington facility. The approval allows expanded production capacity for the company’s cartilage repair therapy. The new ...